Den Europæiske Union - dansk - EMA (European Medicines Agency)

roche registration gmbh - ocrelizumab - multipel sclerose - immunosuppressiva - behandling af voksne patienter med recidiverende former for multipel sklerose (rms) med aktiv sygdom defineret ved kliniske eller billeddannende egenskaber. behandling af voksne patienter med tidlig primær progressiv multipel sklerose (ppm) i form af sygdommens varighed og grad af handicap, og med billedbehandling funktioner karakteristisk for inflammatorisk aktivitet.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - dimethylfumarat - enterokapsler, hårde - 240 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 240 mg